Check eligibility
Answer a short 2-minute questionnaire so we can understand your goals and medical history.

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.
Includes a medical consultation and prescription, if clinically appropriate, with your treatment dispensed and delivered to your home. Ongoing clinical follow-ups and check-ins are provided to support your treatment and monitor progress.
Identity verification is required before a prescription can be issued and this medication dispensed. You’ll be asked to provide valid ID after placing your order. Accepted forms of ID include a national ID card, passport, or driving licence.
Type of medicine
GLP-1 receptor agonist
Works by
Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.
Active ingredient
Semaglutide
Effective within
Within a few weeks.
Generic?
No
Side effects
Nausea, diarrhea, hypoglycemia (low blood sugar), stomach discomfort, and gastrointestinal upset.
Clinician-led care, designed to be simple from start to finish.
Answer a short 2-minute questionnaire so we can understand your goals and medical history.
If eligible, one of our doctors issues your free prescription within 24 hours.
Next-day delivery across the EU, with support at every step of your treatment.
Wegovy tablets are a once-daily oral medication containing semaglutide, a GLP-1 receptor agonist developed by Novo Nordisk (The same ingredient found in Ozempic and Wegovy injection pens). The medication is indicated for adults with obesity or overweight conditions accompanied by weight-related health complications, Wegovy is also approved to reduce cardiovascular risk in patients with established heart disease.
Semaglutide functions as a GLP-1 receptor agonist, promoting satiety and reducing appetite to support sustainable weight management when combined with dietary modification and physical activity. Treatment requires medical supervision and adherence to a structured dose escalation protocol.
The main ingredient in Wegovy is semaglutide. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. This means it mimics the action of natural hormones that regulate appetite and food intake in the body. GLP-1 receptor agonists work by reducing hunger and increasing feelings of fullness, leading to decreased food intake and, consequently, weight loss. Semaglutide is administered via injection and is designed to be used alongside a reduced-calorie diet and increased physical activity for the management of obesity or overweight in adults with certain weight-related medical conditions.
If you have any questions, please do not hesitate to contact us. We will respond as quickly as possible, within 24 hours on business days.
Contact us
Contact us with any questions or comments. Our team is available by email at info@medetone.com to provide the support you need.
Delivery information
Receive your orders quickly and reliably. Choose from several delivery options at checkout for added convenience and speed. All orders placed before 3:00 pm are processed the same day.
Customer service
Our dedicated team is here to support you at every step. Contact us for assistance with orders, tests, or any other enquiries. We are available Monday to Friday from 8:00 am to 5:00 pm, and Saturday from 9:00 am to 1:00 pm.
FAQ’s
Find answers to frequently asked questions about our services, tests, and procedures. Our help centre provides quick solutions and detailed information.